跳至主要内容
临床试验/NCT02470624
NCT02470624Unknown不适用

Chinese Acute Ischemic Stroke Treatment Outcome Registry

Peking University First Hospital1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2015年5月最近更新:
适应症

试验速览

阶段
不适用
入组人数
10,000
试验地点
1
主要终点
death or severe disability

研究概览

简要总结

This is a multi-center registry study. The investigators will include 10,000 patients with confirmed acute ischemic stroke in China. The aim of the study is to survey current treatment situation in China and compare the effectiveness and safety between different intervention regimens.

详细描述

Stroke is a common disease in China. Compared to western countries, there are many treatment regimens used in clinical practice in China. But their treatment effects are not well validated. The aim of the study is to survey current treatment situation in China and compare the effectiveness and safety between different intervention regimens.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥18 yesrs
  • confirmed diagnosis of an ischemic stroke
  • admission within 1 week after onset of stroke or within treatment time window for patients of thrombolysis treatment
  • signed informed consent

排除标准

  • with intracerebral hemorrhage
  • with severe morbid (estimated survival duration less than 3 months)
  • could not provide follow-up information

结局指标

主要结局

death or severe disability

时间窗: 90 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yining Huang

Professor

Peking University First Hospital

研究点 (1)

Loading locations...

相似试验